Henry Schein said it reached a deal that will result in its dismissal “with prejudice” as a defendant in the opioid litigation involving Summit County, Ohio, in the U.S. District Court for the Northern District of Ohio.
Other reports indicated that distributors AmerisourceBergen Corp, Cardinal Health and McKesson and Israel-based drugmaker Teva Pharmaceutical Industries are expected to announce a settlement today. Henry Schein also said that it will pay $250,000 of Summit County’s expenses as well.
“The opioid crisis is a terrible national tragedy, and all segments of society need to come together to address the crisis,” Schein CEO Stanley Bergman said. “We look forward to playing a constructive role in helping to advance solutions that put an end to opioid addiction.”
He said Melville-based Henry Schein will make a $1 million donation to establish an educational foundation with Summit County “to develop best practices regarding the proper use and prescription of opioids.”
